BANK OF AMERICA CORP /DE/ - ANIKA THERAPEUTICS INC ownership

ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 129 filers reported holding ANIKA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of ANIKA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,394,103
-3.6%
74,831
+34.5%
0.00%
Q2 2023$1,445,656
-13.7%
55,645
-4.6%
0.00%
Q1 2023$1,674,979
+16.8%
58,321
+20.3%
0.00%
Q4 2022$1,434,623
+47.1%
48,467
+18.4%
0.00%
Q3 2022$975,000
+76.3%
40,943
+65.4%
0.00%
Q2 2022$553,000
-21.2%
24,750
-11.5%
0.00%
Q1 2022$702,000
-56.9%
27,957
-38.5%
0.00%
Q4 2021$1,629,000
+107.8%
45,478
+146.8%
0.00%
Q3 2021$784,000
-3.1%
18,429
-1.3%
0.00%
Q2 2021$809,000
-47.8%
18,668
-50.8%
0.00%
Q1 2021$1,549,000
+167.5%
37,960
+196.6%
0.00%
Q4 2020$579,000
-32.6%
12,797
-47.3%
0.00%
Q3 2020$859,000
+15.5%
24,277
+23.2%
0.00%
Q2 2020$744,000
+53.4%
19,713
+17.4%
0.00%
Q1 2020$485,000
+1.5%
16,788
+82.3%
0.00%
Q4 2019$478,000
-45.9%
9,211
-42.8%
0.00%
Q3 2019$884,000
-15.0%
16,117
-37.1%
0.00%
Q2 2019$1,040,000
-12.1%
25,626
-34.5%
0.00%
Q1 2019$1,183,000
+71.4%
39,105
+90.5%
0.00%
Q4 2018$690,000
+153.7%
20,526
+218.5%
0.00%
Q3 2018$272,000
+73.2%
6,444
+30.9%
0.00%
Q2 2018$157,000
-53.1%
4,924
-26.8%
0.00%
Q1 2018$335,000
-51.2%
6,725
-47.1%
0.00%
Q4 2017$686,000
-34.1%
12,718
-29.2%
0.00%
Q3 2017$1,041,000
+4.4%
17,961
-11.2%
0.00%
Q2 2017$997,000
-1.5%
20,218
-13.2%
0.00%
Q1 2017$1,012,000
+75.4%
23,295
+97.7%
0.00%
Q4 2016$577,000
+1031.4%
11,784
+1017.0%
0.00%
Q3 2016$51,000
-20.3%
1,055
-11.8%
0.00%
Q2 2016$64,000
-59.2%
1,196
-65.9%
0.00%
Q1 2016$157,000
+10.6%
3,510
-5.6%
0.00%
Q4 2015$142,000
-36.0%
3,719
-46.6%
0.00%
Q3 2015$222,000
-57.0%
6,965
-55.4%
0.00%
Q2 2015$516,000
+207.1%
15,619
+282.7%
0.00%
Q1 2015$168,000
-58.0%
4,081
-58.4%
0.00%
Q4 2014$400,000
+270.4%
9,819
+234.3%
0.00%
Q3 2014$108,000
+468.4%
2,937
+621.6%
0.00%
Q2 2014$19,000
-93.5%
407
-94.2%
0.00%
Q1 2014$291,000
-36.2%
7,075
-40.8%
0.00%
Q4 2013$456,000
+1040.0%
11,955
+615.4%
0.00%
Q3 2013$40,000
+90.5%
1,671
+36.7%
0.00%
Q2 2013$21,0001,2220.00%
Other shareholders
ANIKA THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Euclidean Technologies Management, LLC 44,875$2,031,0002.14%
Parian Global Management LP 102,705$4,648,0001.16%
CAPITAL MANAGEMENT CORP /VA 93,035$4,211,0001.15%
Avidity Partners Management LP 731,000$33,085,0001.07%
Sio Capital Management, LLC 65,382$2,959,0000.61%
DIKER MANAGEMENT LLC 21,835$988,0000.50%
Archon Capital Management LLC 48,925$2,214,0000.38%
Caption Management, LLC 362,800$16,420,0000.37%
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC 1,546,260$69,984,0000.20%
Boston Trust Walden Corp 378,167$17,116,0000.18%
View complete list of ANIKA THERAPEUTICS INC shareholders